International Stem Cell Corp. to Host Conference Call on Friday, March 22 to Discuss Positive Study Data of Parkinson's Disease
March 21, 2013 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwire - Mar 21, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company,...
International Stem Cell Corporation Announces Positive Stem Cell Data in Parkinson's Disease
March 20, 2013 08:00 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwire - Mar 20, 2013) - International Stem Cell Corporation (ISCC) (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company focused on the...
International Stem Cell Corporation Announces Positive Results of Primate Parkinson's Study
March 19, 2013 08:00 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwire - Mar 19, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company focused on the therapeutic...
International Stem Cell Corporation Technology for Deriving Neuronal Cell Published by Nature Publishing Group
March 15, 2013 08:40 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwire - Mar 15, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company focused on the therapeutic...
International Stem Cell Corporation Raises Additional Capital
March 14, 2013 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwire - Mar 14, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company focused on the...
International Stem Cell Corporation to Present at 65th American Academy of Neurology Annual Meeting
March 05, 2013 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwire - Mar 5, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company focused on the therapeutic...
International Stem Cell Corporation Strengthens Intellectual Property Portfolio
February 15, 2013 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwire - Feb 15, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company,...
International Stem Cell Corporation Demonstrates Positive Animal Efficacy Results in Metabolic Liver Disease Program
February 12, 2013 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwire - Feb 12, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company") a California-based biotechnology company,...
International Stem Cell Corporation Announces Positive Results From In Vivo Animal Study of Parkinson's Disease
February 04, 2013 08:00 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwire - Feb 4, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company") a California-based biotechnology company, today...
International Stem Cell Corporation Announces Positive Animal Efficacy Results in Liver Disease Program
January 07, 2013 08:00 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwire - Jan 7, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company") a California-based biotechnology company,...